Abstract
The aim of this paper was to review the current state of resistance to beta-lactam antibiotics mediated by the production of extended spectrum beta-lactamases (ESBLs) in Pseudomonas aeruginosa and Acinetobacter baumannii strains. The majority of ESBLs belong to SHV, TEM, and CTX-M and less often to BES, GES, VEB, and PER families, while sometimes the ESBLs cannot be included in any defined family. The review is focusing on the main ESBL types circulating in Romanian hospitals and their association with multi-drug resistance phenotypes. The contribution of proteomics and nanotechnology to the development of novel and accurate diagnosis tools of ESBL-producing Gram-negative, non- fermentative bacilli is highlighted.
Keywords: Acinetobacter baumannii, ESBLs producers, Pseudomonas aeruginosa, β-lactams.
Graphical Abstract
Related Journals
Current Bioactive Compounds
Combinatorial Chemistry & High Throughput Screening
Current Diabetes Reviews
Current Enzyme Inhibition
Current Molecular Medicine
Current Medicinal Chemistry
Current Pharmaceutical Biotechnology
Current Topics in Medicinal Chemistry
Current Protein & Peptide Science
Medicinal Chemistry
Related Books
Opportunities for Biotechnology Research and Entrepreneurship
Research Methodology and Project Management in Biotechnology
Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective
Recent Trends In Livestock Innovative Technologies
Algal Biotechnology for Fuel Applications
Terpenoids: Recent Advances in Extraction, Biochemistry and Biotechnology
Recent Advances in Biotechnology
16